Zusammenfassung
Die Neuroborreliose ist klinisch und laborchemisch meist gut zu diagnostizieren. Leitsymptome sind radikuläre Schmerzen sowie Paresen der Extremitäten und des N. facialis. Die Vielzahl weiterer seltener neurologischer Symptome lässt sich durch die Liquoranalyse in der Regel gut zuordnen. Die Therapie mit Doxycyclin (oral), Cephalosporinen der 3. Generation (Ceftriaxon, Cefotaxim) oder Penicillin G (i.v.) orientiert sich an der klinischen Symptomatik (zentral, peripher). Das Post-Lyme-Syndrom ist eine diffuse Beschreibung unspezifischer Beschwerden, die keine sichere Kausalität mit einer vorausgegangen Borrelieninfektion aufweisen. Die Pathogenese ist unklar, eine Erregerpersistenz kann, bei unauffälligem Liquor und fehlendem Behandlungserfolg von Antibiotika in gut geplanten Studien, weitestgehend ausgeschlossen werden.
Summary
Neuroborreliosis is easily diagnosed by means of clinical symptoms and laboratory findings. Guiding symptoms are radicular pain and pareses of the extremities and the facial nerve. There is a great number of further less frequently occurring neurological symptoms, which can be attributed to a borrelial infection only by appropriate investigations of the CSF. Radiculitis is cured adequately by oral doxycycline while symptoms of the central nervous system are probably better treated intravenously by ceftriaxone, cefotaxime or penicillin G. Post-Lyme syndrome is a diffuse description of non-specific complaints, which are not the explicit result of a former infection with B. burgdorferi. As further antibiotics do not help and the CSF is unremarkable in most patients, a persistent infection with B. burgdorferi s.l. in all probability can be excluded.
Literatur
Benke T, Gasse T, Hittmair-Delazer M, Schmutzhard E (1995) Lyme encephalopathy: long-term neuropsychological deficits years after acute neuroborreliosis. Acta Neurol Scand 91:353–357
Brorson O, Brorson SH (1997) Transformation of cystic forms of borrelia burgdorferi to normal, mobile spirochetes. Infection 25:240–246
Bujak DI, Weinstein A, Dornbush RL (1996) Clinical and neurocognitive features of the post Lyme syndrome. J Rheumatol 23:1392–1397
Bunikis J, Barbour AG (2002) Laboratory testing for suspected Lyme disease. Med Clin North Am 86:311–340
Carod AF, Perez L, Gracia NM, Giron MJ (1994) Failure of empirical treatment with ceftriaxone in motor neuron disease. Fracaso del tratamiento empirico con ceftriaxona en la enfermedad de la motoneurona. Neurologia 9:29–31
Christen HJ (1996) Lyme neuroborreliosis in children. Ann Med 28:235–240
Christen HJ, Bartlau N, Hanefeld F et al (1990) Peripheral facial palsy in childhood–Lyme borreliosis to be suspected unless proven otherwise. Acta Paediatr Scand 79:1219–1224
Coyle PK (2000) Chronic meningitis. Curr Treat Options Neurol 2(4):375–387
Coyle PK, Schutzer SE (2002) Neurologic aspects of Lyme disease. Med Clin North Am 86:261–284
Dotevall L, Hagberg L (1989) Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis. Antimicrob Agents Chemother 33:1078–1080
Dotevall L, Hagberg L (1999) Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis 28:569–574
Elkins LE, Pollina DA, Scheffer SR, Krupp LB (1999) Psychological states and neuropsychological performances in chronic Lyme disease. Appl Neuropsychol 6:19–26
Fallon BA, Nields JA (1994) Lyme disease: a neuropsychiatric illness. Am J Psychiatry 151:1571–1583
Fallon BA, Nields JA, Parsons B et al (1993) Psychiatric manifestations of Lyme borreliosis. J Clin Psychiatry 54:263–268
Fingerle V, Schulte-Spechtel UC, Ruzic-Sabljic E et al (2008) Epidemiological aspects and molecular characterization of borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int J Med Microbiol 298:279–290
Finizia C, Jonsson R, Hanner P (2001) Serum and cerebrospinal fluid pathology in patients with sudden sensorineural hearing loss. Acta Otolaryngol 121:823–830
Gutacker M, Valsangiacomo C, Balmelli T et al (1998) Arguments against the involvement of borrelia burgdorferi sensu lato in alzheimer’s disease. Res Microbiol 149:31–37
Halperin JJ, Kaplan GP, Brazinsky S et al (1990) Immunologic reactivity against borrelia burgdorferi in patients with motor neuron disease. Arch Neurol 47:586–594
Halperin JJ, Shapiro ED, Logigian E et al (2007) Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 69:91–102
Heller J, Holzer G, Schimrigk K (1990) Immunological differentiation between neuroborreliosis and multiple sclerosis. J Neurol 237:465–470
Holmgren AR, Matteson EL (2006) Lyme myositis. Arthritis Rheum 54:2697–2700
Jacobi C, Schwark C, Kress B et al (2006) Subarachnoid hemorrhage due to borrelia burgdorferi-associated vasculitis. Eur J Neurol 13:536–538
Kaiser R (1994) Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients. J Neurol 242:26–36
Kaiser R (2004) Clinical courses of acute and chronic neuroborreliosis following treatment with ceftriaxone. Nervenarzt 75:553–557
Kaiser R, Lucking CH (1993) Intrathecal synthesis of specific antibodies in neuroborreliosis. Comparison of different ELISA techniques and calculation methods. J Neurol Sci 118:64–72
Kaplan RF, Jones-Woodward L (1997) Lyme encephalopathy: a neuropsychological perspective. Semin Neurol 17:31–37
Kaplan RF, Meadows ME, Vincent LC et al (1992) Memory impairment and depression in patients with Lyme encephalopathy: comparison with fibromyalgia and nonpsychotically depressed patients. Neurology 42:1263–1267
Kaplan RF, Trevino RP, Johnson GM et al (2003) Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurology 60:1916–1922
Karkkonen K, Stiernstedt SH, Karlsson M (2001) Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis. Scand J Infect Dis 33:259–262
Kindstrand E, Nilsson BY, Hovmark A et al (2000) Polyneuropathy in late lyme borreliosis – a clinical, neurophysiological and morphological description. Acta Neurol Scand 101(1):47–52
Klempner MS, Hu LT, Evans J et al (2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345:85–92
Kraemer JD, Gostin LO (2009) Science, politics and values: the politicization of professional practice guidelines. JAMA 301:665–667
Kristoferitsch W, Baumhackl U, Sluga E et al (1987) High-dose penicillin therapy in meningopolyneuritis Garin-Bujadoux-Bannwarth. Clinical and cerebrospinal fluid data. Zentralbl Bakteriol Mikrobiol Hyg (A) 263:357–364
Kruger H, Reuss K, Pulz M et al (1989) Meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a follow-up study of 72 patients over 27 years. J Neurol 236:322–328
Krupp LB, Hyman LG, Grimson R et al (2003) Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 60:1923–1930
Krupp LB, Masur D, Schwartz J et al (1991) Cognitive functioning in late Lyme borreliosis. Arch Neurol 48:1125–1129
Lebech AM (2002) Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification. APMIS Suppl 1–40
Ljostad U, Mygland A (2008) CSF B–lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J Neurol 255:732–737
Ljostad U, Skogvoll E, Eikeland R et al (2008) Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol 7:690–695
Logigian EL, Kaplan RF, Steere AC (1990) Chronic neurologic manifestations of Lyme disease. N Engl J Med 323:1438–1444
Magid D, Schwartz B, Craft J, Schwartz JS (1992) Prevention of Lyme disease after tick bites. A cost-effectiveness analysis. N Engl J Med 327:534–541
Maiwald M, Oehme R, March O et al (1998) Transmission risk of Borrelia burgdorferi sensu lato from Ixodes ricinus ticks to humans in southwest Germany. Epidemiol Infect 121:103–108
Marques AR, Weir SC, Fahle GA, Fischer SH (2000) Lack of evidence of Borrelia involvement in Alzheimer’s disease. J Infect Dis 182(3):1006–1007
Meer-Scherrer L, Chang LC, Adelson ME et al (2006) Lyme disease associated with Alzheimer’s disease. Curr Microbiol 52:330–332
Meier C, Grahmann F, Engelhardt A, Dumas M (1989) Peripheral nerve disorders in Lyme-Borreliosis. Nerve biopsy studies from eight cases. Acta Neuropathol 79:271–278
Miklossy J (2008) Chronic inflammation and amyloidogenesis in Alzheimer’s disease – role of spirochetes. J Alzheimers Dis 13:381–391
Mygland A, Skarpaas T, Ljostad U (2006) Chronic polyneuropathy and Lyme disease. Eur J Neurol 13:1213–1215
Oksi J, Nikoskelainen J, Hiekkanen H et al (2007) Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis 26:571–581
Pappolla MA, Omar R, Saran B et al (1989) Concurrent neuroborreliosis and Alzheimer’s disease: analysis of the evidence. Hum Pathol 20:753–757
Peltomaa M, Pyykko I, Sappala I et al (2000) Lyme borreliosis, an etiological factor in sensorineural hearing loss? Eur Arch Otorhinolaryngol 257(6):317–322
Peltomaa M, Pyykko I, Seppala I, Viljanen M (1998) Lyme borreliosis–an unusual cause of vertigo. Auris Nasus Larynx 25:233–242
Pfister HW, Einhaupl KM, Wilske B, Preac-Mursic V (1987) Bannwarth’s syndrome and the enlarged neurological spectrum of arthropod-borne borreliosis. Zentralbl Bakteriol Mikrobiol Hyg (A) 263:343–347
Piesman J, Mather TN, Sinsky RJ, Spielman A (1987) Duration of tick attachment and Borrelia burgdorferi transmission. J Clin Microbiol 25:557–558
Porcella SF, Schwan TG (2001) Borrelia burgdorferi and treponema pallidum: a comparison of functional genomics, environmental adaptations and pathogenic mechanisms. J Clin Invest 107:651–656
Rauer S, Kaiser R, Kölmel W et al (2008) Neuroborreliose. In Diener HC, Putzki N (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart, NY S 415–424
Reimer B, Erbas B, Lobbichler K et al (2002) Seroprevalence of Borrelia infection in occupational tick-exposed people in Bavaria (Germany). Int J Med Microbiol 291 [Suppl 33]:215
Reimers CD, de Koning J, Neubert U et al (1993) Borrelia burgdorferi myositis: report of eight patients. J Neurol 240:278–283
Rupprecht TA, Elstner M, Weil S, Pfister HW (2008) Autoimmune-mediated polyneuropathy triggered by borrelial infection? Muscle Nerve 37:781–785
Rupprecht TA, Koedel U, Angele B et al (2006) Cytokine CXCL13–a possible early CSF marker for neuroborreliosis. Nervenarzt 77:470–473
Rupprecht TA, Koedel U, Fingerle V, Pfister HW (2008) The pathogenesis of lyme neuroborreliosis: from infection to inflammation. Mol Med 14:205–212
Schafers M, Neukirchen S, Toyka KV, Sommer C (2008) Diagnostic value of sural nerve biopsy in patients with suspected Borrelia neuropathy. J Peripher Nerv Syst 13:81–91
Schmutzhard E (2002) Multiple sclerosis and Lyme borreliosis. Wien Klin Wochenschr 114:539–543
Schmutzhard E, Stanek G, Pletschette M et al (1988) Infections following tickbites. Tick-borne encephalitis and Lyme borreliosis–a prospective epidemiological study from tyrol. Infection 16:269–272
Steere AC (1989) Lyme disease. N Engl J Med 321:586–596
Wilske B (2002) Microbiological diagnosis in Lyme borreliosis. Int J Med Microbiol 291 [Suppl 33]:114–119
Wilske B, Fingerle V, Schulte-Spechtel U (2007) Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol 49:13–21
Wormser GP, Dattwyler RJ, Shapiro ED et al (2006) The clinical assessment, treatment and prevention of lyme disease, human granulocytic anaplasmosis and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43:1089–1134
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaiser, R., Fingerle, V. Neuroborreliose. Nervenarzt 80, 1239–1251 (2009). https://doi.org/10.1007/s00115-009-2788-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-009-2788-z